Open AccessA Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma
Author(s) -
Laura Raftery,
Joel E. Tepper,
Richard M. Goldberg,
A. William Blackstock,
Mebea Aklilu,
Stephen Bernard,
Anastasia Ivanova,
Janine Marie Davies,
Bert H. O’Neil
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5pb0-4m76
Subject(s) - gemcitabine , oxaliplatin , erlotinib , medicine , oncology , radiation therapy , cohort , chemotherapy , colorectal cancer , cancer , epidermal growth factor receptor